Janelia scientists find that a molecule best known for its role in pain perception also plays an important role in regulating body weight.
HHMI scientists have pioneered the use of genome editing to trace lineage in living systems.
HHMI Investigator David E. Clapham, MD, PhD, will become Vice President and Chief Scientific Officer, effective September 1, 2016.
Zoghbi shares Shaw Prize for research leading to discovery of genes and proteins involved in Rett syndrome.
Researchers have discovered that fat tissue is a previously unrecognized reservoir of trypanosomes, the parasites that cause sleeping sickness.
Ninety-one schools have been invited to submit full proposals to apply for grants through HHMI’s $60 million Inclusive Excellence initiative that is encouraging colleges and universities to broaden access to science excellence for all students.
HHMI scientists have designed a potential cancer therapy that uses a unique strategy to block a molecule that drives the growth of cancer.
A new partnership between HHMI’s Educational Media Group and the Biomedical Neuroscience Institute (BNI) at Universidad de Chile will provide teachers and students in Latin America with free access to science education materials produced by HHMI BioInteractive.